Skip to content
10-K

Annual Report

Evolutionary Genomics, Inc.

0001553350-22-000231

← back to feed
Filed
Mar 22, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 17, 2022 5.88M sh
Current Liabilities FY 2021 · Dec 31, 2021 $18.87K
Current Liabilities FY 2021 · Dec 31, 2020 $3.16K
Stockholders Equity FY 2021 · Sep 30, 2021 −$3.79M
Stockholders Equity FY 2021 · Jun 30, 2021 −$2.78M
Stockholders Equity FY 2021 · Mar 31, 2021 −$2.28M
Stockholders Equity FY 2021 · Sep 30, 2020 −$169.67K
Stockholders Equity FY 2021 · Jun 30, 2020 −$760.48K
Stockholders Equity FY 2021 · Mar 31, 2020 −$520.61K
Stockholders Equity FY 2021 · Dec 31, 2019 −$333.73K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$2.3M
Long Term Debt FY 2021 · Dec 31, 2020 $2.25M
Cash And Equivalents FY 2021 · Dec 31, 2020 $215.84K
Total Liabilities FY 2021 · Dec 31, 2020 $2.25M
Current Assets FY 2021 · Dec 31, 2020 $277.59K
Total Assets FY 2021 · Dec 31, 2020 $3.99M
Sga Expense FY 2021 · Dec 31, 2020 $603.63K
Rd Expense FY 2021 · Dec 31, 2020 $1.79M
Net Income FY 2021 · Dec 31, 2020 −$1.71M
Operating Income FY 2021 · Dec 31, 2020 −$2.88M
Revenue FY 2021 · Dec 31, 2020 $12.5K